Trial reportBMC pregnancy and childbirth2026
Carbetocin versus oxytocin with or without tranexamic acid for preventing postpartum hemorrhage in cesarean delivery: a randomized controlled trial.
Trial report in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostpartum hemorrhage (PPH) is a significant contributor to maternal morbidity, particularly following cesarean deliveries. Uterotonics, including oxytocin and carbetocin, are commonly used to prevent PPH. However, the comparative effectiveness of these agents when used in conjunction with tranexamic acid remains uncertain.
aimsThis study aims to evaluate the efficacy of carbetocin, oxytocin, and their combinations with tranexamic acid in mitigating intraoperative blood loss during cesarean deliveries.
methodsIn this randomized, double-blind, two-factorial trial, 200 women scheduled for cesarean sections were allocated into four groups (n = 50 each): carbetocin (100 µg), carbetocin combined with tranexamic acid, oxytocin (5 IU), and oxytocin combined with tranexamic acid. The interventions were administered intravenously immediately after delivery. The primary outcome was estimated intraoperative blood loss in the first 24 h, assessed through suction volume and gauze counts. Secondary outcomes included hematological parameters (hemoglobin, hematocrit) and hemodynamic changes (blood pressure, heart rate).
resultsThe carbetocin group demonstrated significantly lower blood loss (629.0 ± 139.62 mL) compared to the oxytocin plus tranexamic acid group (712.7 ± 131.32 mL; p = 0.017). Post-hoc analysis revealed no significant difference in blood loss between the carbetocin and oxytocin-alone groups. Carbetocin also resulted in the smallest decreases in hematocrit (-2.01%) and hemoglobin (-0.99 g/dL), along with minimal changes in blood pressure (+ 1.60 mmHg systolic, + 3.42 mmHg diastolic). In contrast, the oxytocin groups exhibited greater hemodynamic fluctuations, characterized by significant reductions in blood pressure and increases in heart rate (p < 0.001). Significant differences in hematocrit, white blood cell count, and blood pressure changes were observed between the groups (p < 0.05). No significant differences in adverse effects were identified among the groups.
conclusionIn this trial, carbetocin was associated with less blood loss than oxytocin combined with tranexamic acid and demonstrated a more favorable hemodynamic profile compared to oxytocin-based regimens. These findings suggest it may be considered a preferred uterotonic agent for the prevention of PPH in cesarean deliveries, though the role of tranexamic acid requires further clarification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.